In the case of CHEK1, CDC25A, and CCNE1, we observed contrasting associations compared to hsa‐miR‐195‐5p and hsa‐miR‐497‐5p with the clinical data, where elevated levels of these genes were linked to high‐grade carcinomas, increased expression of Ki‐67, and (except for CHEK1) were associated with the HER2 and PR‐negative status. This evidence concerns the gene CHEK1 and carcinoma.